Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Andrew, Bruening"'
Autor:
Servane Lachize, Carlos A. Obejero-Paz, Shushant Jain, Tiffany Snow, Andrew Bruening-Wright, Peter Hawryluk
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 105:106815
Publikováno v:
Biophysical Journal. 114:623a-624a
Autor:
Brian Roche, Jennifer Shaffer, Carlos A. Obejero-Paz, Michelle Waines, John Ross, Andrew Bruening-Wright
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Publikováno v:
Biophysical Journal. 110(3)
The effect of drugs on the extracellular field potential of stem cell cardiomyocytes is one of the three components of the new Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative promoted by the FDA to assess the proarrhythmic potential of n
Autor:
Carlos A. Obejero-Paz, James Kramer, Brian M. Roche, Andrew Bruening-Wright, John Ross, Michelle Waines
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 93:119
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 61:277-286
Introduction The cardiac action potential (CAP) of stem cell-derived human cardiomyocytes (SC-hCMs) is potentially the most powerful preclinical biomarker for cardiac safety and efficacy in humans. Our experiments tested this hypothesis by examining
Publikováno v:
The Journal of General Physiology
Small conductance calcium-gated potassium (SK) channels share an overall topology with voltage-gated potassium (K(v)) channels, but are distinct in that they are gated solely by calcium (Ca(2+)), not voltage. For K(v) channels there is strong evidenc
Publikováno v:
The Journal of Neuroscience. 27:270-278
Hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels are activated by hyperpolarizations that cause inward movements of the positive charges in the fourth transmembrane domain (S4), which triggers channel opening. If HCN channels are he
Autor:
Arthur M. Brown, James Kramer, Peter Hawryluk, Howard C. Dittrich, Milos Tatalovic, Carlos A. Obejero-Paz, Andrew Bruening-Wright
Publikováno v:
Scientific Reports
Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy. Although a potent blocker of hERG, it produced no serious adverse events. We attributed the unexpected result to offsetting Multiple Ion Ch